Reports


Biologics Safety Testing Market: by Product (Services, Instruments and Reagents and Kits); by Test Type (Bioburden tests, Adventitious Agent Detection Tests, Residual Host Contamination Detection Tests, Cell Line Authentication and Characterization Tests, Sterility Tests, Endotoxin Tests and Other Test Types); by Application (Tissue and Tissue-related Products Testing, Cellular and Gene Therapy, Blood and Blood-related Products Testing, Vaccine and Therapeutics Development and Stem Cell Research)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020 - 2029

  • TBI892978
  • July 24, 2020
  • Global
  • 132 pages
  • SAC Insights
                                              Abstract
                    
According to the report, global demand for biologics safety testing market was valued at approximately USD 3.16 billion in 2018, and is expected to generate revenue of around USD 6.79 billion by end of 2025, growing at a CAGR of around 11.6% between 2019 and 2025.

The report covers forecast and analysis for the biologics safety testing market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the biologics safety testing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the biologics safety testing market on a global as well as regional level.

In order to give the users of this report a comprehensive view on the biologics safety testing market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the biologics safety testing market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the biologics safety testing market on global and regional basis.

The study provides a crucial view on the biologics safety testing by segmenting the market based on product, technology, test type, application and region. All the segments of biologics safety testing market have been analyzed based on present and future trends and the market is estimated from 2018 to 2025.

Biologics products referred to the products that are derives from biological sources. Biologics are used in animals and humans as medicines. These biologics include products derived from serum and blood, large polypeptides, vaccines, antitoxins, toxins, viruses etc. Biologics safety is an important parameter for their use in animals and humans and also for regulatory approvals.

The demand for biologics safety testing market is driven by increasing demand for biologics for treating various chronic diseases burden, increasing investments in life science research and development, rapid growth in new product launches, growth in pharmaceutical and biopharmaceutical research and increasing prevalence of chronic disorders. However, stringent regulatory requirements and longer approval time may act as a restraining factor for the market growth. Increased preference for pharmaceutical outsourcing and emerging markets are expected to act as new growth opportunities for major market players of biologics safety testing.

Based on product, global biologics safety testing market is bifurcated services, instruments and reagents and kits. Reagents and kits segment held largest market share in 2018 due to repeated and consistent use of reagents and kits. Services segment will register rapid growth in the coming years with increasing demand for outsourcing services.

Based on test types market is segmented into bioburden tests, adventitious agent detection tests, residual host contamination detection tests, cell line authentication and characterization tests, sterility tests, endotoxin tests and other test types. Endotoxin test type segment held largest market share in 2018. sterility test type segment will witness highest growth rate over the forecast period.

The application segment is divided into tissue and tissue-related products testing, cellular and gene therapy, blood and blood-related products testing, vaccine and therapeutics development and stem cell research. Vaccine and therapeutics development was the largest application segment for biologics safety testing market in 2018. Increasing vaccine and therapeutic drug development activities by major biopharmaceutical and pharmaceutical companies has attributed to the largest market share.

North America dominated the global biologics safety testing market in 2018. Increasing focus on new vaccine and therapeutics development by pharmaceutical and biopharmaceutical companies, availability of funds, growing R&D investments, presence of developed R&D infrastructure, and technological advancements are factors driving the market in this region. Europe was second largest regional market. High R&D spending, growing biologics development projects, government support for R&D and presence of developed infrastructure are some of factors that boost market growth in this region. Latin America is expected to witness considerable growth in the coming years. Asia Pacific region will exhibit highest growth for biologics safety testing market in the coming years. Increasing R&D spending, focus of contract research organizations on capturing growth avenues in developing countries, increasing healthcare spending, and increasing chronic disease burden are factors propelling biologics safety testing market growth in Asia Pacific. Lack of infrastructure and funds may attribute to slower growth in Middle East and Africa.

Major players included in the report are SGS SA, Merck KGaA, Charles River Laboratories, Lonza Group LTD., Toxikon Corporation, Pace Analytical Services Inc., Cytovance Biologics, Inc., Sartorius AG, Thermo Fisher Scientific Inc. and WuXi Apptec among others.

The report segment of global biologics safety testing market as follows:

Global Biologics Safety Testing Market: By Product

	Reagents and Kits
	Services
	Instruments

Global Biologics Safety Testing Market: By Test Type

	Endotoxin Tests
	Sterility Tests
	Cell Line Authentication and Characterization Tests
	Residual Host Contamination Detection Tests
	Adventitious Agent Detection Tests
	Bioburden tests
	Other Tests

Global Biologics Safety Testing Market: By Application

	Vaccine and Therapeutics Development
	Blood and Blood-related Products Testing
	Cellular and Gene Therapy
	Tissue and Tissue-related Products Testing
	Stem Cell Research

Global Biologics Safety Testing Market: By Region

	North America
	
		U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa 

Table of Contents
                    
                    
                         Request Table Of Content
                         Click To Request Sample
                    
                        
List of Figures

1. Market research process
2. Market research methodology
3. Global biologics safety testing market, 2016-2025 (USD Million)
4. Porter’s five forces analysis: biologics safety testing market
5. Global biologics safety testing market attractiveness, by product
6. Global biologics safety testing market attractiveness, by test ty
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form